Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI.
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Levetiracetam (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Therapeutic Use
- 11 Mar 2015 According to Agenebio media release complete phase 2 results were published in Neurolmage: Clinical.
- 31 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Mar 2012 Planned end date changed from 1 Oct 2011 to 1 Oct 2012 ClinicalTrials.gov.